​

Funding Round

Series A - Odyssey Therapeutics

Series A - Odyssey Therapeutics

Investment Firm

Overview

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Announced Date

Dec 07, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorLogos Capital
Participant InvestorHBM Healthcare Investments
Participant InvestorOrbiMed
Participant InvestorSR One
Participant InvestorForesite Capital

Round Details and Background

Odyssey Therapeutics raised $218000000 on 2021-12-07 in Series A

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 07, 2021
Series A - Odyssey Therapeutics
8-218.0M
Oct 13, 2022
Series B - Odyssey Therapeutics
16-168.0M
Dec 05, 2023
Series C - Odyssey Therapeutics
21-101.0M

Recent Activity

There is no recent news or activity for this profile.